Topical prostaglandin analog (PGE2) in vitiligo - A preliminary study

International Journal of Dermatology

Volumn 41, Issue 12, 2002, Pages 942-945

  Parsad, Davinder ^a   Pandhi, Roma ^a   Dogra, Sunil ^a   Kumar, Bhushan ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E2 DERIVATIVE;

ADOLESCENT; ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPIGMENTATION; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE EXACERBATION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GEL; GENERAL CONDITION DETERIORATION; HUMAN; HYPERPIGMENTATION; MALE; PATIENT MONITORING; PIGMENT DISORDER; SKIN IRRITATION; SKIN PIGMENTATION; TREATMENT OUTCOME; TREATMENT PLANNING; VITILIGO;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; DINOPROSTONE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OXYTOCICS; SEVERITY OF ILLNESS INDEX; SKIN PIGMENTATION; TIME FACTORS; VITILIGO;

EID: 0036938538     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2002.01612.x     Document Type: Conference Paper

References (12)

1. Mosher DB, Fitzpatrick TB, Ortonne JP, Hori Y. Hypomelanosis and hypermelanosis. In: Freedberg IM, Eisen AZ, Wolff K, et al., eds. Fitzpatrick's Dermatology in General Medicine. Philadelphia: McGraw-Hill, 1999; 945-1001.
2. Friedmann PS, Wren FE, Mathews JN. Ultraviolet stimulated melanogenesis by human melanocytes is augmented by di-acyl-glycerol but not TPA. J Cell Physiol 1990; 142: 334-341.
3. 2 on the configuration of normal human melanocytes in vitro. J Invest Dermatol 1987; 89: 299-301.
4. Nordlund JJ, Collins CE, Rheins LA. Prostaglandin E2 and D2 but not MSH stimulate the proliferation of pigment cells in the pinnal epidermis of the DBA/2 mouse. J Invest Dermatol 1986; 86: 433-437.
5. Passi S, Grandinetti M, Maggio F, et al. Epidermal oxidative stress in vitiligo. Pigment Cell Res 1998; 11: 81-85.
6. Parsad D, Saini R, Nagpal R. Calcipotriol in vitiligo: A preliminary study. Pediatr Dermatol 1999; 16: 317-320.
7. Parsad D, Saini R, Verma N. Combination of PUVAsol and topical calcipotriol in vitiligo. Dermatology 1998; 197: 167-170.
8. 2 and arachdionate on melanosomes in melanocytes and keratinocytes of anagen hair bulbs in-vitro. J Invest Dermatol 1975; 64: 332-337.
9. Wand M, Conn H, Ritch R, et al. Latanoprost and periocular skin color changes. Arch Ophthalmol 2001; 119: 614-615.
10. Prota G, Vincensi MR, Napolitano A, et al. Latanoprost stimulates eumelanogenesis in iridial melanocytes of cynomolgus monkeys. Pigment Cell Res 2000; 13: 147-150.
11. 2 and thromboxane A2 metabolites in peripheral node efferent lymph of sheep following draiange area immunization. J Immunol 1993; 151 (4): 2142-2149.
12. Henke PK, Bergamini TM, Brittain KR, Polk HC Jr. Prostaglandin E2 modulates monocyte MHC-II (Ia) suppression in biomaterial infection. J Surg Res 1997; 69(2): 372-378.